MDXH

MDxHealth SA

0.1505

Nov 11 • 1:34 PM ET +0.0112 (8.04%)

Healthcare Diagnostics & Research Belgium Nano NASD

Peers: VCYT MYGN OPK CSTL XGN NEO BDSX TECH IMDX PRPO

| Held by: IWC

Scroll to Statements

Index	-
Market Cap	14.36M
Enterprise Value	101.00M
Income	-37.34M
Sales	111.57M
Book/sh	-0.59
Cash/sh	0.20
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	364
IPO	Nov 04, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	0.13
P/B	-
P/C	0.75
P/FCF	-
EV/EBITDA	-
EV/Sales	0.91
Quick Ratio	0.98
Current Ratio	1.15
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.73
EPS next Y	-0.28
EPS next Q	-0.09
EPS this Y	24.38%
EPS next Y	44.08%
EPS next 5Y	40.66%
EPS past 3/5Y	37.71% 27.91%
Sales past 3/5Y	42.79% 42.48%
EPS Y/Y TTM	16.23%
Sales Y/Y TTM	12.75%
EPS Q/Q	-50.77%
Sales Q/Q	2.27%
Earnings	Nov 12 AMC
EPS/Sales Surpr.	6.93% 4.07%

Insider Own	31.90%
Insider Trans	7.80%
Inst Own	36.61%
Inst Trans	46.78%
ROA	-25.87%
ROE	-2440.41%
ROIC	-50.70%
Gross Margin	59.15%
Oper. Margin	-19.01%
Profit Margin	-33.46%
SMA20	-23.32%
SMA50	-67.10%
SMA200	-89.09%
Trades

Shs Outstand	95.42M
Shs Float	64.98M
Short Float	1.41%
Short Ratio	0.15
Short Interest	0.92M
52W High	4.49 -96.65%
52W Low	0.14 8.04%
Volatility	12.76% 18.34%
ATR (14)	0.03
RSI (14)	25.43
Beta	0.84
Rel Volume	0.22
Avg Volume	6.17M
Volume	858,185

Perf Week	-3.77%
Perf Month	-77.20%
Perf Quarter	-67.42%
Perf Half Y	-92.28%
Perf YTD	-95.78%
Perf Year	-96.62%
Perf 3Y	-94.66%
Perf 5Y	-98.63%
Perf 10Y	-
Recom	2.67
Target Price	1.12
Prev Close	0.14
Price	0.15
Change %	8.04%

Consensus

Hold

Avg. Price Target

$1.12

Implied Upside

+644.2%

Analysts6incl. previous ratings

Rating Distribution2 Buy · 4 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 19, 2026	Downgrade	BBTIG Research	Buy → Neutral
Oct 16, 2026	Downgrade	LLake Street	Buy → Hold	$0.50	+232.2%
Oct 16, 2026	Downgrade	CCraig Hallum	Buy → Hold
May 14, 2026	Downgrade	WWilliam Blair	Outperform → Mkt Perform
Jul 17, 2025	Initiated	CCraig Hallum	Buy	$8	+5,215.6%
Oct 31, 2024	Initiated	LLake Street	Buy	$7	+4,551.2%
May 31, 2023	Initiated	TTD Cowen	Outperform	$7	+4,551.2%
Jul 18, 2022	Resumed	OOppenheimer	Outperform	$18	+11,860.1%

Nov-04-26 06:07PM	MDxHealth Faces Credibility Test After Pre-Announced Revenue Miss And Suspended 2026 Outlook (Earnings Whispers)
Oct-29-26 04:00PM	Mdxhealth to Release Third Quarter 2026 Financial Results on November 12 (GlobeNewswire) -5.63% -9.88%
Oct-15-26 04:00PM	MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance (GlobeNewswire) -65.77%
Aug-14-26 01:03AM	MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic ... (GuruFocus.com) +74.89%
Aug-13-26 04:00PM	Mdxhealth Reports Second Quarter 2026 Financial Results (GlobeNewswire)
04:00PM	Loading…
Jul-30-26 04:00PM	Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 (GlobeNewswire)
Jul-24-26 04:59PM	Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency (GlobeNewswire)
Jul-02-26 04:00PM	Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) -6.02%
Jun-29-26 08:00AM	Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial (GlobeNewswire) -6.28%
May-14-26 01:02AM	MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Focus Amid ... (GuruFocus.com) -49.50%
May-13-26 04:00PM	Mdxhealth Reports Q1-2026 Results (GlobeNewswire)
Apr-30-26 04:00PM	Mdxhealth to Release First Quarter 2026 Financial Results on May 13 (GlobeNewswire)
Mar-16-26 04:00PM	Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 (GlobeNewswire) +5.31%
Feb-27-26 12:07AM	MDxHealth SA (MDXH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising Losses (GuruFocus.com)
Feb-26-26 05:48PM	MDxHealth Q4 Earnings Call Highlights (MarketBeat)
04:00PM	Loading…
04:00PM	Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results (GlobeNewswire)
Feb-12-26 05:00PM	Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 (GlobeNewswire)
Jan-12-26 08:00AM	MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences (GlobeNewswire) +5.21%
Jan-07-26 08:21AM	MDxHealth announces next phase of collab with University of Oxford (TipRanks)
Jan-06-26 08:00AM	Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer (GlobeNewswire)
Nov-13-25 12:00AM	MDxHealth SA (MDXH) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Acquisitions ... (GuruFocus.com)
Nov-12-25 04:01PM	Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 (GlobeNewswire) -7.42%
Nov-03-25 04:01PM	Mdxhealth to Release Third Quarter 2025 Financial Results on November 12 (GlobeNewswire)
Oct-29-25 08:50AM	Here's Why Momentum in MDxHealth SA (MDXH) Should Keep going (Zacks)
Sep-21-25 09:16AM	MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics (Insider Monkey)
Sep-15-25 05:29PM	Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne (GlobeNewswire)
Aug-06-25 03:27AM	MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +10.44%
Aug-05-25 08:00PM	MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:30PM	Bio-Techne Announces Exosome Diagnostics Divestiture (PR Newswire)
04:01PM	Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne (GlobeNewswire)
01:00PM	Loading…
Jul-03-25 01:00PM	Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change (GlobeNewswire)
May-15-25 03:15AM	MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... (GuruFocus.com) +6.74%
May-14-25 05:10PM	MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	MDxHealth Reports Q1-2025 Results (GlobeNewswire)
May-13-25 09:45AM	MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
May-08-25 05:50PM	10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +5.85%
May-07-25 05:25PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-30-25 04:00PM	Mdxhealth to Release First Quarter 2025 Financial Results on May 14 (GlobeNewswire)
Mar-06-25 09:35AM	Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) (Zacks)
Feb-27-25 02:21AM	MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges (GuruFocus.com)
Feb-26-25 05:10PM	MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.15%
04:00PM	Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 04:00PM	Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 (GlobeNewswire)
Jan-13-25 05:00AM	MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance (GlobeNewswire)
Nov-25-24 08:30AM	MDxHealth to Participate in Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-07-24 02:29AM	MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Nov-06-24 04:00PM	MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024 (GlobeNewswire)
Nov-05-24 08:08AM	What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings (GuruFocus.com)
Oct-28-24 05:01PM	MVM Partners, LLC Increases Stake in MDxHealth SA (GuruFocus.com)
Oct-14-24 08:00AM	MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6 (GlobeNewswire)
Sep-25-24 09:31PM	MDxHealth Announces Pricing of Offering of Ordinary Shares (GlobeNewswire) -21.26%
04:05PM	MDxHealth Announces Launch of Offering of Ordinary Shares (GlobeNewswire)
Aug-21-24 08:53PM	MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) -12.23%
04:00PM	MDxHealth Reports Q2 and Half Year 2024 Results (GlobeNewswire)
Aug-12-24 04:00PM	MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21 (GlobeNewswire)
Jul-08-24 08:00AM	MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance (GlobeNewswire) +21.37%
08:00AM	Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors (GlobeNewswire)
May-15-24 04:00PM	Mdxhealth to Present at Upcoming Investor Conferences (GlobeNewswire)
May-06-24 08:52AM	MDxHealth SA (NASDAQ:MDXH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 01:53PM	MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +6.80%
07:45AM	MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed (GlobeNewswire)
Mar-28-24 01:30PM	These 2 Strong Buy Penny Stocks Could Go Boom, Say Analysts (TipRanks) +5.28%
Mar-12-24 04:00PM	Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering (GlobeNewswire) -8.77% +10.00%
Mar-07-24 10:42AM	MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Call Transcript (Insider Monkey) -17.43%
Mar-06-24 04:00PM	Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Feb-21-24 05:00PM	MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 (GlobeNewswire)
Feb-16-24 08:45AM	Mdxhealth Announces Resignation of Board Member (GlobeNewswire)
Jan-08-24 04:00PM	MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance (GlobeNewswire)
Dec-18-23 01:00AM	MDxHealth Announces Completion of Transition to Single Listing on Nasdaq (GlobeNewswire)
Nov-27-23 01:00AM	MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq (GlobeNewswire) -7.36%
Nov-14-23 04:00PM	MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 04:00PM	MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights (GlobeNewswire) +13.48%
Nov-08-23 04:00PM	MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 (GlobeNewswire) -14.19%
Nov-06-23 01:00AM	MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation (GlobeNewswire)
Oct-25-23 04:00PM	MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 (GlobeNewswire)
Oct-20-23 04:00PM	Mdxhealth's New Share Capital Amount and New Number of Shares (GlobeNewswire)
Oct-09-23 04:00PM	MDxHealth Reports Preliminary Q3-2023 Revenues (GlobeNewswire) +18.22%
Oct-02-23 04:04PM	MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting (GlobeNewswire) -8.57% -10.94%
Sep-26-23 04:46PM	Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer (GlobeNewswire)
Aug-23-23 04:00PM	MDxHealth Reports Q2 and Half Year 2023 Results (GlobeNewswire) -5.98%
Aug-10-23 04:00PM	MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 (GlobeNewswire) +5.68%
Aug-09-23 04:00PM	Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealths Select mdx for Prostate Cancer Test (GlobeNewswire)
Aug-03-23 07:25PM	AMN Healthcare Services (AMN) Beats Q2 Earnings and Revenue Estimates (Zacks) +8.12%
Jun-30-23 04:00PM	MDxHealth Announces Results of its Extraordinary General Shareholders Meeting (GlobeNewswire) +6.56%
Jun-05-23 05:30PM	MDxHealth Announces its Extraordinary General Shareholders Meeting (GlobeNewswire)
May-25-23 04:30PM	MDxHealth Announces Results of its Annual and Extraordinary General Shareholders Meetings (GlobeNewswire) -7.55% +7.58%
May-23-23 04:00PM	MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference (GlobeNewswire)
May-15-23 04:00PM	MDxHealth Reports Q1-2023 Results (GlobeNewswire) +14.13%
May-01-23 04:00PM	MDxHealth to Present First Quarter 2023 Financial Results on May 15 (GlobeNewswire) -5.36%
Apr-25-23 04:00PM	MDxHealth Announces its Ordinary and Extraordinary General Shareholders Meetings (GlobeNewswire)
Apr-19-23 04:00PM	Foundational LCD Covers Select mdx for Prostate Cancer (GlobeNewswire) +14.97%
Apr-07-23 04:30PM	MDxHealth Shareholder Transparency Declaration (GlobeNewswire)
Mar-13-23 02:00AM	MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank (GlobeNewswire) -11.53%
Mar-08-23 05:00PM	MDxHealth Announces Update of Outstanding Shares and Voting Rights (GlobeNewswire) -10.57%
04:00PM	MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023 (GlobeNewswire)
Mar-06-23 05:34PM	MDxHealth Announces Exercise of Option (GlobeNewswire)
Mar-03-23 04:30PM	MDxHealth Shareholder Transparency Declarations (GlobeNewswire)
Feb-28-23 04:30PM	MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-22-23 04:30PM	MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bleichroeder LP	10% Owner	Sep 17 '26	Proposed Sale	0.70	1,500,000	1,056,900		Sep 17 05:42 PM
MVM Partners, LLC	Director	Aug 13 '26	Buy	0.45	2,202,643	1,000,000	6,903,100	Aug 17 04:05 PM

MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

CEO & Executive DirectorMr. Michael K. McGarrity

Interim Chief Financial OfficerMr. Ron Kalfus CPA

LLMMr. Joseph Sollee J.D.

Chief Commercial OfficerMr. John A. Bellano

Vice President of Finance & AccountingMr. Scott McMahan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

MDXH

MDxHealth SA

Upgrade your Finviz experience

All the Features.
Half the Price.